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Abstract 23 
Introduction: To compare acute mechanical and metabolic responses of the diaphragm and rib 24 
cage inspiratory muscle during two different types of respiratory loading in patients with COPD. 25 
Methods: In 16 patients (age:65±13, 56% male, FEV1:60±6%pred, Pimax:82±5%pred) 26 
assessments of respiratory muscle electromyography (EMG), esophageal (Pes) and gastric (Pga) 27 
pressures,  breathing pattern, and noninvasive assessments of systemic (VO2, cardiac output, 28 
oxygen delivery and extraction) and respiratory muscle hemodynamic and oxygenation 29 
responses (blood flow index [BFI], oxygen delivery index, deoxyhemoglobin concentration 30 
[HHb] and tissues oxygen saturation [StiO2]), were performed under two different conditions of 31 
respiratory muscle loading (hyperpnea and loaded breathing). 32 
Results: During hyperpnea, breathing frequency, minute ventilation, esophageal and diaphragm 33 
pressure-time product (PTP)/min, cardiac output and VO2 were higher than during loaded 34 
breathing (P<0.05). Average inspiratory Pes and Pdi per breath scalene (SCA), 35 
sternocleidomastoid (SCM), and intercostal muscle activation was higher during loading 36 
breathing (P<0.05). Higher Pdi during loaded breathing compared to hyperpnea was due to 37 
higher Pes (P<0.05). Diaphragm activation, inspiratory and expiratory Pga and expiratory 38 
abdominal muscle activation did not differ between the two conditions (P>0.05). SCA-BFI and 39 
oxygen delivery index were lower and SCA-HHb was higher during loaded breathing. 40 
Furthermore, SCA and intercostal muscle StiO2 were lower during loaded breathing compared to 41 
hyperpnea (P<0.05).   42 
Conclusion: Greater inspiratory muscle effort during loaded breathing evoked larger ribcage and 43 
neck muscle activation compared to hyperpnea. In addition, lower SCA and intercostal muscles 44 
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StiO2 during loading breathing than during hyperpnea might indicates a mismatch between 45 
inspiratory muscle oxygen delivery and utilization. 46 
Key Words: RESPIRATORY MUSCLE ACTIVATION, RESPIRATORY MUSCLE 47 
LOADING, RESPIRATORY MUSCLE METABOLISM, RESPIRATORY MUSCLE 48 
TRAINING. 49 
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INTRODUCTION 50 
Improvements in both respiratory muscle endurance and strength can be observed in 51 
patients with COPD after either whole-body, or specific respiratory muscle endurance 52 
training.(1-3) The improvements in respiratory muscle function in response to endurance training 53 
are probably mainly due to the increased ventilatory demands induced by (exercise) hyperpnea. 54 
Hyperpneic training provides a high respiratory flow / low resistance stimulus to the respiratory 55 
muscles during a high number of consecutive repetitions.(2, 3) It has also been demonstrated that 56 
adding specific hyperpneic (i.e. endurance) respiratory muscle training can enhance the effects of 57 
whole body endurance training on respiratory muscle endurance. However, larger improvements 58 
in inspiratory muscle strength (i.e., pressure generating capacity) have been reported after 59 
specific inspiratory muscle strength training (IMT) in comparison with whole body endurance 60 
training (i.e. average increases of 16 vs 6 cmH2O in maximal inspiratory mouth pressure [MIP] 61 
respectively).(4, 5)  During inspiratory muscle strength training loading is induced by 62 
overcoming a  “high external resistance” during a limited number of breathing cycles per session 63 
(e.g. 30-40 full vital capacity breaths against loads equaling about 30-50% of MIP).(4) 64 
Therefore, as much as limb muscles respond distinctively to endurance and strengthening 65 
stimuli,(6, 7) it can also be expected that different responses are induced when the respiratory 66 
muscles are exposed to “endurance” (i.e., hyperpnea) or “strengthening” (i.e., loaded breathing) 67 
stimuli. Differences in acute responses to either endurance or strengthening stimuli imposed on 68 
the respiratory muscle in terms of muscle recruitment and activation patterns as well as local and 69 
systemic oxygenation responses have however, to the best of our knowledge, never been 70 
comprehensively characterized. Therefore, we aimed to explore and compare the acute responses 71 
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of a number of physiological variables during these two different types of inspiratory muscle 72 
loading in patients with COPD.. 73 
METHODS 74 
Subjects. Sixteen symptomatic patients (Baseline Dyspnea Index 6 ± 1),(8) with  a clinical 75 
diagnosis of COPD according to the Global Initiative for Chronic Obstructive Pulmonary 76 
Disease (GOLD),(9) aged between 55 and 74 years (see online supplement) were included in the 77 
study. The study was approved by the local hospital ethics committee (reference number: 78 
S58513). Before participation in the study, all patients were informed about potential risks and 79 
discomforts associated with performing the experiments and provided written informed consent. 80 
Study design. Experiments were performed on two visits. During the first visit (i.e., 81 
initial testing) patients performed comprehensive pulmonary function testing.(10, 11) Maximal 82 
inspiratory muscle strength was measured by maximum inspiratory mouth pressures (MIP).(12, 83 
13)  An incremental cardiopulmonary exercise test (CPET),(14) and a constant work rate cycle 84 
endurance test (CWRT),(14) were also performed during this visit (see supplemental online 85 
material for more details). During the second visit, patients performed, in random order, both a 86 
Normocapnic Hyperpnea trial (hyperpnea),(13, 15) reproducing the ventilatory responses (i.e., 87 
mean tidal volume, breathing frequency and minute ventilation) recorded for each patient during 88 
the CWRT,(15) and a Tapered Flow Resistive Loading task (loaded breathing) reproducing 89 
ventilator loading during a high-intensity IMT session.(13, 16)  Both tasks were performed for 90 
five minutes. Breathlessness was measured by the modified Borg scale at rest and at the end of 91 
each task.(17) Additionally, during the final 60 seconds of both the hyperpnea and loaded 92 
breathing tasks, respiratory muscle perfusion,(18) oxygen delivery,(19) respiratory muscle 93 
activation (root mean square EMG%max) and respiratory effort were assessed.(13, 20-23) 94 
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Metabolic and ventilatory variables were also assessed breath by breath during both tasks by a 95 
metabolic cart (Vmax 229; Sensor Medics, Anaheim, CA, USA). 96 
Hyperpnea. Patients were requested to maintain tidal volume, breathing frequency and 97 
minute ventilation reproducing their own breathing responses recorded during the CWRT for 98 
five minutes.(15) Thus, during the test investigators provided continuous verbal guidance aiming 99 
to maintain a maximum variation in minute ventilation of 5% throughout the test.(15) Visual 100 
feedback on breathing parameters was also provided on a screen displayed in front of the patient 101 
so as to adjust his/her breathing frequency and tidal volume to the level required by the 102 
investigator. Normocapnia was maintained by having subjects inspire from a Douglas bag 103 
containing 5% CO2, 21% O2 and 74% N2 for balance, connected to a two-way non-rebreathing 104 
valve (model 2700, Hans Rudolph) by a piece of tubing.(15)  105 
Loaded breathing. The loaded breathing training session was performed in accordance 106 
with previously published protocols of IMT using the electronic POWERbreathe KH2 107 
device.(16)  Subjects were requested to breathe out completely (i.e., until residual volume) 108 
through a loaded breathing device (POWERbreathe KH2) followed by full vital capacity 109 
inspirations against an external resistance of ~50% of patients MIP for 30 breaths or for a 110 
minimum of five minutes.(16) Thereby loading the inspiratory muscles throughout their full 111 
range of motion in accordance with a previously published method.(16) 112 
Respiratory muscle pressures, work of breathing and activation during hyperpnea 113 
and loaded breathing. Respiratory muscle pressures and diaphragm activation (EMGdi) were 114 
measured by a combined multipair esophageal electrode catheter with esophageal- and gastric-115 
balloons (Yinghui Medical Equipment Technology Co. Ltd., Guangzhou, China) nasally inserted 116 
after topical anesthesia. Procedures for optimal positioning of the catheter and signal processing 117 
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have already been published.(20)  EMGdi was converted into root mean square (RMS), 118 
normalized by its maximum activation during inspiratory capacity maneuvers (ICs) and reported 119 
as percentage of maximum activation (EMGdi, %max). Continuous measurements of esophageal 120 
(Pes), gastric (Pga) and transdiaphragmatic (Pdi, i.e., Pga - Pes) pressures and its derivatives 121 
were performed.  Inspiratory Pes, Pga and Pdi max were obtained during inspiratory sniff 122 
maneuvers.(20) Expiratory Pga max, however, was obtained during forced expiratory capacity 123 
maneuvers (see online supplement) . Ribcage, i.e., scalene (SCA), sternocleidomastoid (SCM), 124 
parasternal intercostal and 7th intercostal (ICM and 7thICM, respectively), and abdominal (ABD) 125 
muscle activation was measured by surface electromyography (sEMG) (Desktop Direct 126 
Transmission (DTS), NORAXON, Scottsdale, USA).(21) Electrodes were placed (1) on the 127 
posterior left triangle of neck at the level of cricoid process for scalene muscle measurements 128 
(EMGsca), (2) at the midpoint along the long axis of the right sternocleidomastoid muscle 129 
between the mastoid process and the medial clavicle for sternocleidomastoid muscle 130 
measurement (EMGscm), (3) at the right parasternal space of the 2nd and 3rd rib 3 cm lateral to 131 
the sternum for parasternal intercostal muscle measurements (EMGpicm), (4) at the line between 132 
the 7th and 8th intercostal space at mid axillary line for 7th intercostal muscle measurements 133 
(EMG 7th icm), (5) over upper 1/3 of rectus abdominis under costal cartilage level (EMGabd) 134 
(see online supplement)..  135 
Systemic hemodynamic and vascular responses during loaded breathing and 136 
hyperpnea. Cardiac output, heart rate and stroke volume were continuously measured by a 137 
commercial impedance cardiography device (PhysioFlowPF50; Manatec Biomedical, Macheren, 138 
France) previously validated for COPD patients (see online supplement).(24) Estimated systemic 139 
oxygen delivery was calculated by the product of cardiac output and arterial oxygen content. The 140 
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latter was calculated as the product of 1.39 x hemoglobin concentration [Hb] and %SpO2.(25) 141 
Arterio-venous oxygen content (i.e., a-vΟ2 diff) difference was calculated by dividing oxygen 142 
uptake by cardiac output. The systemic oxygen extraction ratio was calculated as the ratio of the 143 
a-vΟ2 diff to arterial oxygen content. In addition, systemic vascular conductance was calculated 144 
by dividing cardiac output by mean arterial blood pressure.  145 
Respiratory muscles perfusion and oxygenation responses. SCA, SCM and 7thICM, 146 
and ABD  blood flow indices (BFI) were calculated by using two commercial Near-Infrared 147 
Spectroscopy (NIRS; NIRO-200 and a NIRO-200NX; HAMAMATSU Photonics KK) devices in 148 
combination with light-absorbing indocyanine green dye (ICG) that was injected through a 149 
peripheral venous catheter as previously described and validated for patients with COPD (see 150 
online supplement). For the above-mentioned respiratory muscles oxygen delivery index was 151 
calculated by the product of BFI and arterial oxygen content. NIRS optodes were placed at the 152 
right posterior triangle of the neck, the left 7th intercostal space and over the upper 1/3 of rectus 153 
abdominis below costal cartilage level to respectively measure SCA, 7thICM and rectus 154 
abdominis muscle perfusion. ICG injections for calculating BFI were performed during the last 5 155 
breaths during loaded breathing and during the last 30 seconds of the hyperpnea trial.  156 
NIRS-derived changes in respiratory muscle deoxyhemoglobin concentration ([HHb]) 157 
was used as an index of respiratory muscle oxygen extraction.(26) NIRS-derived tissue oxygen 158 
saturation index (i.e., StiO2) was considered as a measure of the dynamic balance between local 159 
tissue oxygen delivery and utilization (27) and, therefore, local muscle capacity to match oxygen 160 
supply relative to its metabolic demand (see online supplement) ).  161 
Statistical analysis. A power >0.99 was found based on the difference between SCM 162 
muscle activation (EMGscm,%max) between the three tasks (i.e., rest, hyperpnea and loaded 163 
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breathing, see Data analysis section in the online supplement). Data are expressed as mean ± SE 164 
or mean difference (95% confidence interval). Mean respiratory muscle activation, respiratory 165 
pressures and its derivatives, breathing pattern variables and central hemodynamic and metabolic 166 
variables during the last 60 seconds of rest, hyperpnea and loaded breathing were compared by 167 
one-way repeated measures ANOVA when normal distribution was not violated. Otherwise, the 168 
Friedman test was used. When statistical significance was met (P<0.05) pairwise comparisons 169 
with Holm correction were performed as post-hoc analyses. Changes in respiratory muscle 170 
perfusion and oxygenation responses from rest to hyperpnea versus rest to loaded breathing were 171 
compared by paired t-tests when normally distributed, or by Mann-Whitney tests if normal 172 
distribution assumptions were not met (see online supplement).  173 
RESULTS 174 
Subjects characteristics. Subjects’ characteristics are described in detail in Table 1. The 175 
sample was well balanced regarding sex and composed by patients classified as having mild to 176 
very severe COPD presenting resting lung hyperinflation (i.e., increased RV/TLC) (see Subjects 177 
characteristics in the supplemental material for more details). Six out of the sixteen included 178 
were not willing (n= 5) or able (n= 1) to undergo measurements of EMGdi, Pes and Pga with the 179 
esophageal catheter system.  Three patients did not have respiratory muscle perfusion measured 180 
due to either technical reasons (n=1) or because of contraindications regarding ICG injections 181 
(n=2). Hence, nine out of the sixteen patients had concurrent measurements of EMGdi, 182 
respiratory pressures and respiratory muscle perfusion. There were no differences regarding 183 
pulmonary function, peak exercise and inspiratory muscle capacity between subjects with 184 
EMGdi and respiratory pressures measurements versus those subjects not able or not willing to 185 
undergo these specific experimental procedures.           186 
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Respiratory symptoms during hyperpnea and loaded breathing tasks. Neither 187 
breathlessness nor respiratory effort sensations were statistically different between hyperpnea 188 
and loaded breathing (5 ± 1 vs. 4 ± 1, P=0.15 and 5 ± 1 vs. 5 ± 1, P=0.93, respectively). 189 
Respiratory muscle activation.  We observed similar levels of diaphragm activation 190 
(EMGdi%max) (Figure 1a) between hyperpnea and loaded breathing (P= 0.35). SCM, SCA and 191 
both intercostals muscle activation (i.e., parasternal and 7th intercostal) were significantly higher 192 
during loaded breathing as compared to hyperpnea (Figures 1b – 1e). There were no significant 193 
differences between expiratory activation of the abdominal muscle between hyperpnea and 194 
loaded breathing (EMGabd, %max: 33 ± 4 vs. 30  ±  6, respectively; P=0.27).  195 
Respiratory pressures and work of breathing. Diaphragmatic and esophageal pressures 196 
per breath were significantly higher during loaded breathing in comparison to hyperpnea, gastric 197 
pressure, however, was similar between the two conditions (P= 0.64;Table 2). Pes PTP and Pes 198 
WOB/b were significantly higher during loaded breathing in comparison to hyperpnea (Table 2). 199 
Inspiratory Pga and Pdi WOB/b were significantly greater during loaded breathing as compared 200 
to hyperpnea (Table 2). Pes WOB/min, and Pdi WOB/min tended to be higherduring loaded 201 
breathing in comparison to hyperpnea (P=0.06 and P=0.08 respectively), but Pga WOB/min was 202 
similar (P= 0.96) between the two conditions. Pes, Pga and Pdi PTP/min responses during 203 
hyperpnea were significantly higher as compared to loaded breathing (Table 2). There were no 204 
significant differences in expiratory Pga between hyperpnea and loaded breathing (P= 0.83; 205 
Table 2). 206 
Breathing pattern. In comparison to hyperpnea, absolute and relative inspiratory 207 
volumes were significantly higher during loaded breathing. Respiratory rate and minute 208 
ventilation however, was significantly lower during loading breathing compared to hyperpnea 209 
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(P<0.05; Table 2). Peak inspiratory flow was similar (P=0.20) and accompanied by longer 210 
inspiratory time and lower duty cycle during loaded breathing in comparison to hyperpnea 211 
(P<0.05; Table 2). During hyperpnea, end-inspiratory lung volume (EILV) achieved 81 ± 2% of 212 
the vital capacity  and during  loaded breathing achieved 59 ± 4% of the vital capacity. 213 
Representing an end-inspiratory reserve volume of 1.76 ±0.12 L during hyperpnea and 2.90 ± 214 
0.24 during loaded breathing (P < 0.001).  215 
Systemic hemodynamic, metabolic and cardiovascular responses. Cardiac output, 216 
VO2, a-vΟ2 diff and systemic vascular conductance responses were significantly greater during 217 
hyperpnea than during loaded breathing (P<0.05; Table 3). Mean arterial blood pressure did not 218 
significantly differ between the two conditions (Table 3).     219 
Respiratory muscle perfusion and oxygenation responses. Increases from rest in 220 
SCABFI and oxygen delivery index were significantly less during loaded breathing as compared 221 
to hyperpnea (P<0.05; Table 4). The change from rest in SCA oxygen extraction (i.e., [HHb]) 222 
was significantly higher during loading breathing as compared to hyperpnea (P<0.05; Table 4). 223 
During loading breathing SCA-StiO2 decreased from rest whilst during hyperpnea SCA-StiO2 224 
increased leading to a significant difference in SCA-StiO2 between the two conditions (P<0.05; 225 
Table 4). Increases from rest in 7thICMBFI and oxygen delivery index were less (but not 226 
significant P=0.27 and P=0.26, respectively) during loaded breathing as compared to hyperpnea. 227 
The change from rest in 7thICM-ΗΗΒ tended to be higher during loaded breathing as compared 228 
to hyperpnea (P=0.06).During loading breathing 7thICM -StiO2 decreased from rest whilst during 229 
hyperpnea 7thICM -StiO2 increased leading to a significant difference in 7thICM -StiO2 between 230 
the two conditions (P<0.05; Table 4). No significant changes in BFI (P= 0.09), oxygen delivery 231 
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(P= 0.10), [HHB] (P= 0.11), and StiO2 (P= 0.50) were observed for the ABDs between loaded 232 
breathing and hyperpnea.  233 
DISCUSSION 234 
Main findings. Our key findings are that by engaging either in hyperpnea (endurance 235 
stimulus) or loaded breathing (strength stimulus) differences in both local (i.e., respiratory 236 
muscle) and systemic responses are evoked in patients COPD. In both conditions the increase in 237 
systemic and respiratory muscle hemodynamics from rest seems to increase in association with 238 
the increase in VO2, (Tables 3 and 4). Loaded breathing elicited greater activation of the SCA, 239 
SCM ICM and 7thICM and inspiratory muscle and reduction in SCA and 7thICM-StiO2 (Figure 1 240 
and Table 4, respectively) compared to hyperpnea, thus reflecting the additional burden imposed 241 
on these muscles by a strengthening stimulus in comparison to an endurance loading stimulus 242 
(Table 2). In addition, increases in diaphragmatic activation during hyperpnea and loaded 243 
breathing relative to resting breathing were of similar magnitude in both conditions (Figure 1). 244 
 Respiratory muscle activation during loaded breathing and hyperpnea. The 245 
contribution of SCA, SCM and intercostal muscles to the act of breathing is known to be 246 
amplified with increased ventilatory demands.(28-30) Additionally, increased lung volumes are 247 
known to impact on the length-tension relationship of the diaphragm, by moving it away from its 248 
optimal length to generate pressure.(31-33).(31).  Notably, as compared to diaphragm, increased 249 
lung volumes ensuing less length-tension impairment of SCA, SCM and intercostal muscles. 250 
These muscle undergo less severe length changes resulting in “less” sub-optimal length at higher 251 
volumes,(34-36) thereby relatively preserved  pressure generating capacity.(36) Thus, SCA, 252 
SCM and intercostal muscles recruitment enables the respiratory system to compensate for the 253 
lost efficiency of the diaphragm by increasing lateral, dorsoventral (i.e., intercostals), and cranial 254 
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(i.e., SCA and SCM) displacement of the rib cage.(31), SCA, SCM and intercostal muscles 255 
recruitment serves as a reserve to overcome increasing demands imposed on the respiratory 256 
system under these conditions  (i.e., performing faster and deeper inspiratory maneuvers as well 257 
as against higher loads).(34, 35) In our study, the recruitment of SCA, SCM and both intercostal 258 
muscles was further amplified during loaded breathing (Figure 1) when an additional external 259 
load was imposed on the respiratory system in addition to higher inspiratory volumes and flow 260 
rates. This resulted in further increases in respiratory demands (i.e., increased inspiratory 261 
pressures, WOB and PTP; Table 2).  Furthermore, increases in inspiratory Pdi during loaded 262 
breathing (in comparison with hyperpnea) were mostly due to more negative inspiratory Pes but 263 
not more positive Pga (Table 2; see online supplement). These findings  suggest that SCA, SCM 264 
and intercostal muscles were preferably recruited to perform the additional work imposed on the 265 
inspiratory muscles during loaded breathing.  266 
 Systemic and respiratory muscle metabolism during loaded breathing and hyperpnea. 267 
It is know that during exercise systemic responses such as cardiac output and VO2 increases 268 
proportionally to the work being performed by the working muscles per unit time.(37-39)  Our 269 
study further supports these relations by demonstrating that increases in both VO2 and cardiac 270 
output during hyperpnea and loaded breathing appeared to have strong associations with PTP 271 
expressed per minute rather than per breath (Figure 2). Highlighting that increases in respiratory 272 
muscle oxygen requirements (i.e., cost of breathing) seems to be associated with the cumulative 273 
respiratory muscle effort that is developed during a given task rather than the respiratory muscle 274 
effort of each breath of a given task (figure 2).  275 
The higher levels of both systemic and respiratory muscle oxygen extraction (i.e., a-vO2 276 
difference and oxygen extraction and [HHb], respectively) during hyperpnea in comparison to 277 
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loaded breathing were accompanied by sufficient increase in both systemic and respiratory 278 
muscle  oxygen delivery (Tables 3 and 4), thereby preserving the balance between respiratory 279 
muscle oxygen delivery and utilization  (i.e., StiO2; Table 4). During loaded breathing, however, 280 
despite higher respiratory pressure swings and PTP per breath (Table 2), PTP/min was lower 281 
than during hyperpnea (Table 3). Likewise, increases in VO2 and in cardiac output were less 282 
during loaded breathing in comparison to hyperpnea (Table 3). The lower “systemic” oxygen 283 
requirements (i.e., VO2 and a-vO2 diff, Table 3) during loaded breathing were accompanied by a 284 
smaller increase in respiratory muscle blood flow and oxygen delivery in comparison to 285 
hyperpnea (Table 4). These responses observed during loading breathing resulted in a mismatch 286 
between SCA and 7thICM muscles oxygen delivery and utilization (Table 4), resulting in greater 287 
increases in muscle oxygen extraction (i.e., HHB) and lower StiO2 as compared to hyperpnea 288 
(Table 4). Higher intramuscular tensions imposed during loading breathing, might have 289 
contributed to limiting increased in muscle blood flow and oxygen delivery as compared to 290 
hyperpnea (Table 4).(40) The evidence of high intramuscular pressures during loading breathing 291 
is supported by the results demonstrating that mean arterial pressure did not statistically differ 292 
between the two conditions (Table 3) even that during loading breathing central hemodynamic 293 
responses were significantly lower compared to hyperpnea (Table 3). Indeed, studies have shown 294 
that increases in intramuscular pressure during dynamic exercise can reflexively increase mean 295 
arterial blood pressure (via the activation of the mechanoreceptor-mediated reflex within the 296 
skeletal muscle), the latter increases can be maintained throughout the exercise period.(41)  297 
 General considerations. Collectively, these results seem to support the notion that 298 
additional inspiratory pressures generated during loaded breathing are mainly a consequence of 299 
increased loading and activation of SCA, SCM and both intercostal muscles. The behavior of the 300 
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“respiratory effort-recruitment” ratio,(42) i.e., the “matching” between respiratory muscle effort 301 
(e.g., Pes, %max) and the recruitment of different inspiratory muscles (EMG, %max), is 302 
noteworthy. While during resting breathing a higher ratio indicates a “predominantly diaphragm 303 
contribution to breathing”, with increasing load (i.e., hyperpnea and loaded breathing), the ratio 304 
becomes similar between diaphragm and SCA, SCM and both intercostal muscles, thereby 305 
indicating that SCA, SCM and both intercostal muscles contribution to breathing becomes 306 
equally important as that of the diaphragm (supplemental material Figure E1).   307 
  The observed acute increases in load and work being performed by the inspiratory 308 
muscles during both tasks (Table 2) are known to be important determinants of muscle 309 
improvements after exercise programs.(43) Furthermore, according to the specificity and 310 
overload principles of training,(43) in response to a low load (i.e., pressures), high repetition 311 
(i.e., breathing frequency and duration) and high exercise-volume (i.e., PTP cmH2O/s/min) 312 
(Table 2) stimulus as hyperpnea, an endurance benefit would be expected. While after loaded 313 
breathing, improvements in strength would be anticipated as consequence of the high load (i.e., 314 
pressures), low repetition (i.e., breathing frequency and duration) and high contraction-volume 315 
(PTP cmH2O/s/b) stimulus imposed by this regimen (Table 2). Noteworthy the additional 316 
recruitment of only SCA, SCM and both intercostal muscles (Figure 1) as the strategy to 317 
overcome the load imposed during loaded breathing in comparison to hyperpnea (Table 2) was 318 
accompanied by an increased metabolic burden (Table 3  It is therefore likely these inspiratory 319 
muscles will mostly benefit from this additional stimulus (i.e., increased load).(43)  It has 320 
previously been observed that a period of high intensity inspiratory muscle strength training 321 
resulted in increases in specific hypertrophy of intercostal muscle fibers.(44)  322 
16 
 
 Implications. The differences in physiological responses evoked by these different types 323 
(and intensities) of respiratory muscles loading support observations that had previously been 324 
done in clinical practice. It has long been assumed that while exercise hyperpnea constitutes a 325 
training load to the respiratory muscles a larger stimulus might be applied with specific 326 
respiratory muscle training.(45) This is supported by data from RCTs showing that adding 327 
specific inspiratory muscle strength training resulted in larger improvements in respiratory 328 
muscle function (strength and endurance), exercise capacity (cycling endurance time) and 329 
reduction in dyspnea(1) than standard endurance exercise training alone.(2, 4) The stimulus 330 
imposed during loaded breathing in this study (resembling a specific type of inspiratory muscle 331 
strength training) seems to be a good complimentary training stimulus for the respiratory 332 
muscles in addition to whole body exercise training.(46) Based on our data it provides a different 333 
additional load to the respiratory muscles in comparison to exercise hyperpnea. In contrast with 334 
earlier hypotheses this additional load did not result in stimulating the diaphragm in exceeding a 335 
plateau in motor unit recruitment that is typically observed early during exercise hyperpnea,(47) 336 
but by further stimulating SCA, SCM and intercostal muscle recruitment above levels observed 337 
during exercise breathing. Nevertheless, it is important to stress that the hyperpnea used herein 338 
resembles the load imposed to the respiratory system during exercise hyperpnea (i.e., 70% MVV 339 
for several minutes) and not necessarily loads imposed during specific respiratory muscle 340 
endurance training (i.e., 50 - 70% MVV for 15-30 minutes).(4) Whether higher volumes and 341 
longer durations of specific respiratory muscle endurance training might also lead to differential 342 
activation and recruitment patterns of respiratory muscles in comparison to the relatively short 343 
exercise hyperpnea stimulus provided in our study remains to be investigated.  344 
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 Strengths, limitations and technical considerations. The multitude of variables 345 
simultaneously collected is a strength of the study. It allows the concurrent investigation of the 346 
behavior of respiratory muscles activation, pressure generation and metabolism under the same 347 
stimulus. Unfortunately, however, assessments of blood flow and oxygen requirements of the 348 
diaphragm could not be performed due to methodological and safety issues. A limitation of our 349 
study is the small sample size due to the complexity and the invasiveness of its methods and the 350 
fact that not all subjects were able or willing to undergo all experimental procedures. However, 351 
the sample was powered sufficiently (see Data analysis in the supplemental material for more 352 
details) to detect differences in a wide variety of physiological markers. Moreover, while 353 
reproducing the ventilatory pattern of exercise hyperpnea (i.e., breathing frequency, tidal volume 354 
and ventilation), there were also no statistically significant differences between the expiratory 355 
gastric pressures and expiratory ABD activation that were generated during cycling exercise in 356 
comparison to hyperpnea (Pga cycling 20 ± 3 vs Pga hyperpnea 25 ± 5, cmH2O; P=0.3; EMGabd 357 
cycling 23 ± 4 vs EMGabd hyperpnea 33 ± 4, %max; P=0.10, respectively). Thus, providing an 358 
adequate reproducibility between exercise hyperpnea and the hyperpnea task used in our study. 359 
Arterial oxygen content, a-VO2 diff and systemic oxygen extraction were estimated using 360 
continuous SpO2 measurements at the expense of acceptable reduced accuracy in the hypoxemic 361 
patients compared with invasive arterial blood sampling. In addition, it is known that the EMG 362 
signal from the costal diaphragm can generate noise on the activation of the 7thICM we measured 363 
herein. However, the different pattern of diaphragm and 7thICM activation between loaded 364 
breathing and hyperpnea suggested that this was not the case in our data. Nevertheless, it is 365 
possible that the EMG signal measured at these muscles as well as at SCA and SCM could be, at 366 
least in part, contaminated from nearby activity due to the use of superficial electrodes. In our 367 
18 
 
patients, the contribution of diaphragmatic blood flow to the overall NIRS signal on the 7th 368 
intercostal space is probably limited considering that adipose tissue thickness (fat + skin layer) 369 
(measurements were performed using a Harpenden skinfold caliper) indicated a mean value of 370 
8.2 ± 3.7 mm. Therefore, the maximum penetration depth of NIRS light to the muscle tissue was 371 
reduced to approximately 12 mm. Taking into account the substantial distance between the 372 
sampling point of NIRS on the skin and the diaphragmatic appositional area compared with the 373 
shorter distance to the intercostals we believe that perfusion and oxygenation measures in our 374 
study at this site reflected mostly the external and internal intercostal muscles.  375 
CONCLUSION  376 
During loaded breathing there was greater respiratory muscle effort compare to 377 
hyperpnea which ensued larger ribcage and neck muscle activation during inspirations. This 378 
response reflects the additional burden imposed on these muscles by a strengthening stimulus in 379 
comparison to an endurance loading stimulus. In addition, the decrease in ribcage and neck 380 
muscle tissue oxygen saturation during loading breathing compared to hyperpnea might indicates 381 
a mismatch between inspiratory muscle oxygen delivery and utilization .  382 
 383 
 384 
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Figure 1. Comparisons between the EMG activation among the different tasks.  EMGdi, %max: 553 
relative diaphragmatic activation; EMGsca, %max: relative scalenes activation; EMGscm, 554 
%max: relative sternocleidomastoid activation; EMGicm, %max: relative parasternal intercostal 555 
activation; EMG 7th icm, %max: relative 7th intercostal activation. Boxplots shows median at 556 
central line, first and third quantiles for lower and upper box’s limits, respectively, and minimum 557 
and maximum values for lower and upper limits. Dots are single patients’ values. Dots outside 558 
the limits are outliers’ values. *P <0.05; NS; P >0.05. EMGdi: n= 10; sEMG n= 16. 559 
 560 
Figure 2. Relationship between work og breathing (WOB) and pressure-time product (PTP) with 561 
oxygen consumption (VO2; a and d, respectively) and cardiac output (CO; b and e, respectively); 562 
and between systemic oxygen delivery (O2 del) and oxygen consumption (VO2) and vascular 563 
conductance (Vasc. cond.; c and f, respectively). r: Pearson coefficient correlations; R2: Adjusted 564 
R squared (univariate linear regression); NA: not applicable; NS: P >0.05 (non-significant). Lines 565 
are the best-fitting line and shadow areas are 95% confidence interval. Circles: rest; triangles: 566 
normocapnic hyperpnea; cross: tapered flow resistive loading.567 
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Table 1. Subjects characteristics, pulmonary function and peak exercise and inspiratory muscle 568 
capacity data 569 
 n: 16 
Demographics / Anthropometrics 
Sex, male/female 9  / 7 
Age, yrs 65 ± 13 
BMI, kg/m2 27 ± 1.6 
Pulmonary function 
FEV1, L 1.44 ± 0.15 
FEV1, %pred 60 ± 6 
FVC, L 3.23 ± 0.22 
FVC, %pred 99 ± 8 
FEV1/FVC, %  44 ± 3 
MVV, L/min 52 ± 5 
MVV, %pred 65 ± 8 
TLC, L 6.4 ± 0.46 
TLC, %pred 118 ± 5 
RV, L 3.45 ± 0.33 
RV, %pred 155 ± 12 
RV/TLC, % 54 ± 2 
VC, L 2.9 ± 0.2 
TLCO, mmol/min/kpa 4.3 ± 0.4 
TLCO, %pred 56 ± 4 
28 
 
Peak exercise data and inspiratory muscle capacity 
Wpeak, W 81 ± 7 
Wpeak, %max 71 ± 5 
VO2, peak, L/min 1.371 ± 0.116 
VO2, peak, %max 87 ± 8 
COpeak, L/min 12.0 ± 0.5 
MIP, cmH2O 74 ± 4 
MIP, %pred 82 ± 5 
MIP <LLN,  n(%) 9 (56)  
Hb,  g/dl 14.5 ± 0.3 
Data are mean ± SE or n (%). FEV1: forced expiratory volume in the first second; FVC: forced -570 
vital capacity; MVV: maximum voluntary ventilation; TLC: total lung capacity; RV: residual 571 
volume; TLCO: transfer factor for carbon monoxide; MIP: maximal inspiratory pressure; Insp. 572 
mm. weakness: maximum inspiratory pressure bellow the lower limit of normality; Wpeak; peak 573 
exercise capacity; VO2peak: peak oxygen consumption; COpeak; peak cardiac output; LLN: 574 
lower limit of normality. 575 
 576 
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Table 2. Respiratory pressures and work of breathing and breathing pattern data during hyperpna and loaded breathing  577 
   Mean diff (95% CI) 
 Rest Hyperpnea Loaded breathing Hyperpnea - Rest Loaded breathing - Rest Loaded breathing - Hyperpnea 
Respiratory pressures and work of breathing (n= 10) 
Pes, cmH2O -9 ± 1 -15 ± 1 -35 ± 2 -6 (-11 - -2)* -26 (-30 - -21)* -19 (-24 - -15)* 
Pes, %max 14 ± 2 23 ± 2 54 ± 5 10 (-2 – 21)* 40 (27 – 51)* 30 (18 – 41)* 
inspPga, cmH2O 10 ± 2 12 ± 2 15 ± 4 1 (-9 – 12) 5 (-5 – 15) 3 (-7 – 13) 
expPga, cmH2O 10 ± 1 21 ± 4 21 ± 4 10 (-1 – 21) 11 (0 – 22) 1 (-10 – 12) 
inspPga, %max 21 ±  22 ± 4 26 ± 6 1 (-15 – 17) 5 (-11 – 21) 4 (-12 – 20) 
Pdi, cmH2O 19 ± 1 27 ± 2 50 ± 4 7 (17 - -2)* 30 (40 – 20)* 22 (32 – 12)* 
Pdi, %max 21 ± 2 28 ± 1 53 ± 4 7 (-2 – 16)* 32 (22 – 41)* 24 (15 – 34)* 
Pes WOB, L/cmH2O 6± 1 16 ± 2 113 ± 16 10 (-22 – 42)* 108 (75 – 140)* 97 (65 – 130)* 
inspPga WOB,, L/cmH2O 3 ± 1 9 ± 2 33 ±5 6 (-6 – 17) 30 (18 – 41)* 24 (13 – 36)* 
Pdi WOB, L/cmH2O 7 ± 2 14 ± 4 104 ± 15 7 (-25 – 39)* 97 (65 – 128)* 90 (58 – 122)* 
PTP Pes, cmH2O/s//b 4 ± 0 6 ± 0 8 ± 1 2 (0 – 4)* 4 (-2 – 4)* 2 (0 – 4)* 
inspPTP Pga, cmH2O/s/b 4 ± 1 4 ± 1 3 ± 1 0 (-3 – 3) -1 (4 – 2) -1 (-4 – 2) 
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PTP Pdi, cmH2O/s/b 8 ± 1 10 ± 1 11 ± 1 2 (0 – 6) 3 (0 – 6) 1 (-2 – 4) 
Pes WOB, L/cmH2O/min 95 ± 11 495 ± 62 624 ± 71 400 (209 – 591)* 529 (337 – 720)* 129 (-62 –320)
 
inspPga WOB, L/cmH2O/min 52 ± 7 276 ± 58 198 ± 38 224 (83  - 365)* 147 (6 – 288)* -77 (-218 – 64) 
Pdi WOB,  L/cmH2O/min 109 ± 16 430 ± 107 567 ± 66 321 (64 – 578)* 458 (200 – 715)* 136 (-120 - 394) 
PTP Pes, cmH2O/s/min 71 ± 12 184 ± 16 49 ± 9 112 (69 – 157)* -21 (-66 – 22) -135 (-179– 91)* 
inspPTP Pga, cmH2O/s/min 84 ± 18 142 ± 28 21 ± 7 58 (-12 – 127)* -62 (-132 – 7)* -120 (-190 - -51)* 
PTPPdi,  cmH2O/s/min 154 ± 26 325 ± 35 68 ± 13 171 (79 – 262)* -85(-177 – 6)
* -256 (-348 - -1654.73)* 
Breathing pattern (n= 16) 
 Rest hyperpnea loaded breathing hyperpnea - Rest loaded breathing - Rest loaded breathing - hyperpnea 
VE, L 13 ± 1 38 ± 3 12 ± 1 25 (18 – 32)* -1 (-8 - 5)                 -26 (-33 - -19)* 
Insp. vol., L 0.74 ± 0.06 1.17 ± 0.11 1.9 ± 0.21 0.43 (-0.05 – 0.91)* 1.16 (0.68 – 1.64)*               0.73 (0.25 – 1.21)* 
Bf, b/min 20 ± 1 34 ± 1 7 ± 1 14 (10 – 18)* -13 (-17 - -8)* -27 (-31 - -22)* 
Insp. peak flow, L/sec  0.91 ± 0.05 2.47 ± 0.18 2.23 ± 0.2 1.56 (1.03- 2.09)* 1.32 (0.80 - 1.85)* -0.24 (-0.77 – 0.28) 
Insp. time, s 1.27 ± 0.1 0.67 ± 0.04 2.26 ± 0.22 -0.60 (-1.09 – 0.11)* 0..99 (0.50 – 1.47)* 1.58 (1.10 – 2.07)* 
Ti/Ttot, % 38 ± 1 37 ± 1 24 ± 2 -2 (-6 - 4) -14 (-19 - -8)* -12 (-18 - -7)* 
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Data are mean ± SE or mean difference (95% confidence interval). Ti/Ttot: duty cycle of respiration; Bf: breathing frequency; Pes: 578 
Esophageal pressure; Pdi: Transdiaphragmatic pressure; WOB: work of breathing; PTP: Pressure Time Product. * P <0.05. 579 
 580 
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Table 3. Central hemodynamic and metabolic responses 581 
    Mean diff (95% CI) 
 Rest hyperpnea loaded breathing hyperpnea - Rest loaded breathing - Rest loaded breathing - hyperpnea 
HR, bpm 76 ± 3 90 ± 4 89 ± 4 14 (2 – 26)* 13 (1 – 25)* -1 (-13 – 11) 
SV, ml 70 ± 4 84 ± 6 73 ± 4 15 (-1 – 31)* 4 (-13 – 20) -11 (-27 – 5)* 
CO, L/min 5 .2± 0.3 7.5± 0.5 6.5 ± 0.4 2.3 (0.9– 3.7)* 1.1 (0.2 – 2.6)* -1.1 (-.4 – 0.3)* 
CO, %max 44 ± 3  62 ± 4 54 ± 4 19 (6 – 32) 10 (-3 – 23) -8 (-21 – 5) 
VO2, ml/min 283 ± 20 625 ± 42 443 ± 34 342 (229 – 454)* 161 (46 – 275)* -181 (-296 - -67)* 
VO2, %max 25 ± 4 54 ± 7 39 ± 5 29 (10 – 48)* 13 (-6 – 32)* -16 (-34 – 3)* 
VCO2, ml/min 224 ± 14 412 ± 69 409 ± 32 188 (35 – 341)* 185 (29 – 340)* -4 (-159 – 151) 
CaO2mlO2/100ml 18.9 ± 0.5 19.2 ± 0.5 19.2 ± 0.4 0.3 (-1.2 – 1.9) 0.3 (-1.2 – 1.9) 0 (-1.5 – 1.6) 
O2 delivery, LO2/min 0.98 ± 0.05 1.42 ± 0.1 1.23 ± 0.07 0.44  (0.17– 0.71)* 0.25(-0.01 – 0.52)* -0.18 (-0.45 – 0.08)* 
O2 extraction, % 29 ± 2 46 ± 4 38 ±3 16 (6 - 26* 8 (-2 – 19)* -8 (-18 – 3)* 
a-vO2 difference , mlO2/100ml 5.6 ± 03 8.73 ± 0.75 7.3 ± 0.7 3.2 (1.1 – 5.3)* 1.7 (-0.4 – 3.9)* -1.4 (-3.5 – 0.7)*
 
SVC, ml/min/mmHg 56 ± 3 74 ± 5 63 ± 4 18 (5 – 32)* 7 (-7 – 21)* -11 (-26 – 3)* 
SpO2, % 94 ± 1 95 ± 1 94 ± 1 2 (-1 – 4) 0 (-2 – 3) -1 (-4 – 1) 
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SBP, mmHg 120 ± 3 139 ± 6 133 ± 5 19 (4 – 33)* 13 (-3 – 28)* -5.9(-22 – 10) 
DBP, mmHg 80 ± 2 88 ± 2 90 ± 4 8 (-1 – 17) 10 (1 – 20)* 2 (-8 – 12) 
MAP 93 ± 2 105 ± 3 104 ± 4 12 (2 – 22)* 11 (1 – 21)* -1 (-11 – 10) 
Data are mean ± SE or mean difference (95% confidence interval). HR: heart rate; SV: stroke volume; CO: cardiac output; VO2: 582 
oxygen consumption; VCO2: carbon dioxide production; CaO2; arterial oxygen content; a-vO2 difference: arterio-venous oxygen 583 
difference; SVC: systemic vascular conductance SpO2: peripheral oxygen saturation; SBP: systolic blood pressure; DBP: diastolic 584 
blood pressure; Vasc. Cond.: systemic vascular conductance. *P <0.05. 585 
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Table 4. Respiratory muscles perfusion and oxygenation responses during hyperpna and loaded 588 
breathing 589 
   Mean diff (95% CI) 
 hyperpnea loaded breathing loaded breathing - hyperpnea 
Respiratory muscle perfusion, n= 13 
ΔSCA BFI, nmol/L 4.67 ± 1.3 2.81 ± 1.17 -1.86 (-3.2 -  -0.5)* 
Δ7th IC BFI, nmol/L 0.76 ± 0.2 0.5 ± 0.2 0.27 (-0.78 - 0.2) 
ΔABD BFI, nmol/L 1.2 ± 0.5 0.4 ± 0.3 -0.8 (-1.7 – 0.2) 
Respiratory muscle O2delivery 
ΔSCA O2del, au 90 ± 24 54 ± 22 -36 (-11 - -62)* 
Δ7th IC O2del, au 14 ± 4 10 ± 5 -5 (4 - -14) 
ΔABD O2del, au 23 ± 10  8 ± 6 -14 (3 – 33) 
Respiratory muscle oxygen saturation, n= 15 
ΔSCA StiO2, % 1.25 ± 0.9 -2.84 ± 1.27 -4.1 (-6 - -2.1)* 
Δ7th IC StiO2, % 1.5 ± 0.71 -1.52 ± 0.86 -3 (-4.9 - -1.3)* 
ΔABD StiO2, % 1.00 ± 1.00 -0.40 ± 1.52 -1.38 (-3.6 - 0.9) 
Respiratory muscle oxygen extraction, n= 15 
ΔSCA [HHb], µmol/L 2.94 ± 1.33 7.68 ± 2.08 4.73 (1.88 -7.58)* 
Δ7th IC [HHb], µmol/L 0.42 ± 0.61 1.9 ± 0.87 1.48 (-0.05 - 3) 
ΔABD [HHb], µmol/L -1.67 ± 0.86 0.03 ± 1.1 1.70 (-0.82 - 3.48) 
Data are mean ± SE or mean difference (95% confidence interval). Δ: changes from rest; SCA: 590 
Scalenes; 7th IC: 7th Intercostal; ABD: Rectus Abdominis; [HHb]: deoxyhemoglobin 591 
concentration; StiO2: Tissue oxygen saturation index; BFI: blood flow index. *P <0.05.592 
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Figure 1 593 
 594 
 595 
 596 
36 
 
Figure 2. 597 
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